Cargando…

Development of Novel Male Contraceptives

Unintended pregnancy is surprisingly common, accounting for 40–50% of pregnancies worldwide. Contraception is the most effective means of preventing unintended pregnancy. Seventy percent of all contraceptives are used by women; however, some women are unable to use contraceptives due to health condi...

Descripción completa

Detalles Bibliográficos
Autor principal: Amory, John K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070810/
https://www.ncbi.nlm.nih.gov/pubmed/31618525
http://dx.doi.org/10.1111/cts.12708
_version_ 1783506060613517312
author Amory, John K.
author_facet Amory, John K.
author_sort Amory, John K.
collection PubMed
description Unintended pregnancy is surprisingly common, accounting for 40–50% of pregnancies worldwide. Contraception is the most effective means of preventing unintended pregnancy. Seventy percent of all contraceptives are used by women; however, some women are unable to use contraceptives due to health conditions or side effects. Many men wish to take a more active role family planning, but currently have only two effective male contraceptive options, condoms and vasectomy. Therefore, work to develop novel male contraceptives analogous to popular female methods, such as daily pills or long‐acting shots and implants, is underway. This paper will briefly discuss the pros and cons of condoms and vasectomies, and then review the research into novel methods of male contraception.
format Online
Article
Text
id pubmed-7070810
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70708102020-03-17 Development of Novel Male Contraceptives Amory, John K. Clin Transl Sci Reviews Unintended pregnancy is surprisingly common, accounting for 40–50% of pregnancies worldwide. Contraception is the most effective means of preventing unintended pregnancy. Seventy percent of all contraceptives are used by women; however, some women are unable to use contraceptives due to health conditions or side effects. Many men wish to take a more active role family planning, but currently have only two effective male contraceptive options, condoms and vasectomy. Therefore, work to develop novel male contraceptives analogous to popular female methods, such as daily pills or long‐acting shots and implants, is underway. This paper will briefly discuss the pros and cons of condoms and vasectomies, and then review the research into novel methods of male contraception. John Wiley and Sons Inc. 2019-11-14 2020-03 /pmc/articles/PMC7070810/ /pubmed/31618525 http://dx.doi.org/10.1111/cts.12708 Text en © 2019 The Author. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Reviews
Amory, John K.
Development of Novel Male Contraceptives
title Development of Novel Male Contraceptives
title_full Development of Novel Male Contraceptives
title_fullStr Development of Novel Male Contraceptives
title_full_unstemmed Development of Novel Male Contraceptives
title_short Development of Novel Male Contraceptives
title_sort development of novel male contraceptives
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070810/
https://www.ncbi.nlm.nih.gov/pubmed/31618525
http://dx.doi.org/10.1111/cts.12708
work_keys_str_mv AT amoryjohnk developmentofnovelmalecontraceptives